MedTrace Logo

Study to Evaluate the Safety and Effectiveness of the CODMAN ENTERPRISE® Vascular Reconstruction Device

NCT02532517 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2020-10-23

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to demonstrate effectiveness and safety of the CODMAN ENTERPRISE® Vascular Reconstruction Device and Delivery System.

Conditions

  • Intracranial Aneurysm

Interventions

DEVICE

CODMAN ENTERPRISE® Vascular Reconstruction Device and Delivery System

Sponsors & Collaborators

  • Cerenovus, Part of DePuy Synthes Products, Inc.

    lead INDUSTRY

Principal Investigators

  • Donald Frei, MD · Radiology Imaging Associates

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-01
Primary Completion
2019-01-08
Completion
2019-09-21
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02532517 on ClinicalTrials.gov